Vitamin D Level and its Risk Factors in Type 2 Diabetes Patients with Osteoporosis

Abstract

Objective: To explore the vitamin D level and its risk factors in type 2 diabetes patients with osteoporosis. Methods: Taking the
patients with type 2 diabetes and type 2 diabetes combined with osteoporosis who were diagnosed and treated in a hospital in China from
February 2020 to July 2023 as an example, 100 patients were randomly selected and divided into a control group and an experimental group.
The levels of triglycerides, glycosylated hemoglobin, fasting blood glucose and serum 25 hydroxyVD of the patients in the two experimental
groups were compared. At the same time, the investigation and analysis of osteoporosis risk factors were carried out. Results: Through experimental comparison, it can be concluded that the serum 25 hydroxyVD levels of patients in the control group will be higher than those in the
experimental group. And the serum 25 hydroxyVD of female patients will be significantly lower than that of male patients. The serum level
of 25 hydroxyVD in female patients is negatively correlated with glycated hemoglobin, and P<0.05. Conclusion: The vitamin D deficiency
of type 2 diabetes patients with osteoporosis is more serious than that of single diabetes patients, and the risk of osteoporosis in patients with
BMI and elderly women is higher. It can be concluded that type 2 diabetes patients with osteoporosis need early diagnosis of abnormal bone
density in high-risk groups and early intervention in the process of controlling blood sugar, so as to effectively reduce the probability of osteoporosis and improve the quality of life of patients.